Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Agios Pharmaceuticals Company Profile (NASDAQ:AGIO)

Consensus Ratings for Agios Pharmaceuticals (NASDAQ:AGIO) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $73.50 (28.25% downside)

Analysts' Ratings History for Agios Pharmaceuticals (NASDAQ:AGIO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/19/2014Canaccord GenuityReiterated RatingBuy$97.00 -> $111.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2014Canaccord GenuityInitiated CoverageBuy$97.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2014Goldman SachsDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
7/1/2014Citigroup Inc.Initiated CoverageBuy$58.00ViewTweet This Rating  Share This Rating on StockTwits
6/16/2014JPMorgan Chase & Co.Reiterated RatingOverweight$55.00 -> $60.00ViewTweet This Rating  Share This Rating on StockTwits
4/7/2014Leerink SwannBoost Price Target$51.00 -> $65.00ViewTweet This Rating  Share This Rating on StockTwits
4/7/2014JPMorgan Chase & Co.UpgradeNeutral -> Overweight$40.00 -> $55.00ViewTweet This Rating  Share This Rating on StockTwits
3/28/2014JPMorgan Chase & Co.Boost Price Target$35.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
3/7/2014Leerink SwannBoost Price Target$38.00 -> $51.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
8/19/2013JPMorgan Chase & Co.Initiated CoverageNeutral$35.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Goldman SachsInitiated CoverageBuy$37.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/27/2012 forward)